Logo image of XPOF

XPONENTIAL FITNESS INC-A (XPOF) Stock Fundamental Analysis

USA - NYSE:XPOF - US98422X1019 - Common Stock

8.07 USD
+0.09 (+1.13%)
Last: 10/3/2025, 8:13:34 PM
8.07 USD
0 (0%)
After Hours: 10/3/2025, 8:13:34 PM
Fundamental Rating

3

XPOF gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 135 industry peers in the Hotels, Restaurants & Leisure industry. There are concerns on the financial health of XPOF while its profitability can be described as average. XPOF is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

XPOF had negative earnings in the past year.
In the past year XPOF had a positive cash flow from operations.
In the past 5 years XPOF reported 4 times negative net income.
XPOF had a positive operating cash flow in 4 of the past 5 years.
XPOF Yearly Net Income VS EBIT VS OCF VS FCFXPOF Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

1.2 Ratios

XPOF has a worse Return On Assets (-14.46%) than 85.93% of its industry peers.
With an excellent Return On Invested Capital value of 18.81%, XPOF belongs to the best of the industry, outperforming 91.11% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for XPOF is significantly below the industry average of 15.67%.
The last Return On Invested Capital (18.81%) for XPOF is above the 3 year average (10.38%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -14.46%
ROE N/A
ROIC 18.81%
ROA(3y)-5.36%
ROA(5y)-7.13%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)10.38%
ROIC(5y)N/A
XPOF Yearly ROA, ROE, ROICXPOF Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

1.3 Margins

XPOF has a Operating Margin of 21.52%. This is amongst the best in the industry. XPOF outperforms 82.22% of its industry peers.
Looking at the Gross Margin, with a value of 76.81%, XPOF belongs to the top of the industry, outperforming 91.11% of the companies in the same industry.
XPOF's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 21.52%
PM (TTM) N/A
GM 76.81%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.58%
GM growth 5Y3.29%
XPOF Yearly Profit, Operating, Gross MarginsXPOF Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 50 -50

1

2. Health

2.1 Basic Checks

XPOF has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, XPOF has more shares outstanding
Compared to 5 years ago, XPOF has more shares outstanding
The debt/assets ratio for XPOF is higher compared to a year ago.
XPOF Yearly Shares OutstandingXPOF Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
XPOF Yearly Total Debt VS Total AssetsXPOF Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

Based on the Altman-Z score of -0.67, we must say that XPOF is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of XPOF (-0.67) is worse than 88.89% of its industry peers.
The Debt to FCF ratio of XPOF is 40.17, which is on the high side as it means it would take XPOF, 40.17 years of fcf income to pay off all of its debts.
XPOF has a Debt to FCF ratio (40.17) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 40.17
Altman-Z -0.67
ROIC/WACC1.72
WACC10.91%
XPOF Yearly LT Debt VS Equity VS FCFXPOF Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

2.3 Liquidity

XPOF has a Current Ratio of 0.91. This is a bad value and indicates that XPOF is not financially healthy enough and could expect problems in meeting its short term obligations.
XPOF has a Current ratio of 0.91. This is comparable to the rest of the industry: XPOF outperforms 52.59% of its industry peers.
XPOF has a Quick Ratio of 0.91. This is a bad value and indicates that XPOF is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.84, XPOF is in line with its industry, outperforming 52.59% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.91
Quick Ratio 0.84
XPOF Yearly Current Assets VS Current LiabilitesXPOF Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

3

3. Growth

3.1 Past

XPOF shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -153.13%.
XPOF shows a decrease in Revenue. In the last year, the revenue decreased by -2.84%.
XPOF shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 19.93% yearly.
EPS 1Y (TTM)-153.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%966.67%
Revenue 1Y (TTM)-2.84%
Revenue growth 3Y27.35%
Revenue growth 5Y19.93%
Sales Q2Q%-0.4%

3.2 Future

Based on estimates for the next years, XPOF will show a very strong growth in Earnings Per Share. The EPS will grow by 192.01% on average per year.
Based on estimates for the next years, XPOF will show a small growth in Revenue. The Revenue will grow by 4.23% on average per year.
EPS Next Y516.5%
EPS Next 2Y256.51%
EPS Next 3Y192.01%
EPS Next 5YN/A
Revenue Next Year-3.78%
Revenue Next 2Y-0.52%
Revenue Next 3Y4.23%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
XPOF Yearly Revenue VS EstimatesXPOF Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
XPOF Yearly EPS VS EstimatesXPOF Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 1 -1 2

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for XPOF. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 7.54 indicates a rather cheap valuation of XPOF.
94.81% of the companies in the same industry are more expensive than XPOF, based on the Price/Forward Earnings ratio.
XPOF is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.32, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 7.54
XPOF Price Earnings VS Forward Price EarningsXPOF Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40 60

4.2 Price Multiples

XPOF's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. XPOF is cheaper than 74.07% of the companies in the same industry.
XPOF's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 43.8
EV/EBITDA 8.79
XPOF Per share dataXPOF EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 6 -6

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as XPOF's earnings are expected to grow with 192.01% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y256.51%
EPS Next 3Y192.01%

0

5. Dividend

5.1 Amount

No dividends for XPOF!.
Industry RankSector Rank
Dividend Yield N/A

XPONENTIAL FITNESS INC-A

NYSE:XPOF (10/3/2025, 8:13:34 PM)

After market: 8.07 0 (0%)

8.07

+0.09 (+1.13%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)11-05 2025-11-05/amc
Inst Owners74.33%
Inst Owner Change-1.27%
Ins Owners5.11%
Ins Owner Change23.3%
Market Cap394.14M
Analysts80
Price Target12.58 (55.89%)
Short Float %18.2%
Short Ratio6.6
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.12
Dividend Growth(5Y)N/A
DP-13.14%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-101.56%
Min EPS beat(2)-219.74%
Max EPS beat(2)16.62%
EPS beat(4)1
Avg EPS beat(4)-116.42%
Min EPS beat(4)-219.74%
Max EPS beat(4)16.62%
EPS beat(8)1
Avg EPS beat(8)-85.23%
EPS beat(12)1
Avg EPS beat(12)-168.37%
EPS beat(16)1
Avg EPS beat(16)-164.09%
Revenue beat(2)1
Avg Revenue beat(2)-1.63%
Min Revenue beat(2)-3.27%
Max Revenue beat(2)0.01%
Revenue beat(4)3
Avg Revenue beat(4)0.13%
Min Revenue beat(4)-3.27%
Max Revenue beat(4)3.21%
Revenue beat(8)5
Avg Revenue beat(8)0.37%
Revenue beat(12)9
Avg Revenue beat(12)2.65%
Revenue beat(16)13
Avg Revenue beat(16)5.67%
PT rev (1m)0%
PT rev (3m)-10.48%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-51.83%
EPS NY rev (1m)-5.77%
EPS NY rev (3m)-40.96%
Revenue NQ rev (1m)-0.78%
Revenue NQ rev (3m)-5.94%
Revenue NY rev (1m)-0.54%
Revenue NY rev (3m)-4.22%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 7.54
P/S 1.24
P/FCF 43.8
P/OCF 27.52
P/B N/A
P/tB N/A
EV/EBITDA 8.79
EPS(TTM)-0.17
EYN/A
EPS(NY)1.07
Fwd EY13.27%
FCF(TTM)0.18
FCFY2.28%
OCF(TTM)0.29
OCFY3.63%
SpS6.5
BVpS-2.21
TBVpS-6.76
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -14.46%
ROE N/A
ROCE 23.8%
ROIC 18.81%
ROICexc 20.35%
ROICexgc 125.36%
OM 21.52%
PM (TTM) N/A
GM 76.81%
FCFM 2.84%
ROA(3y)-5.36%
ROA(5y)-7.13%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)10.38%
ROIC(5y)N/A
ROICexc(3y)11.53%
ROICexc(5y)N/A
ROICexgc(3y)87.99%
ROICexgc(5y)N/A
ROCE(3y)13.14%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.58%
GM growth 5Y3.29%
F-Score4
Asset Turnover0.79
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 40.17
Debt/EBITDA 4.25
Cap/Depr 36.24%
Cap/Sales 1.68%
Interest Coverage 1.64
Cash Conversion 17.26%
Profit Quality N/A
Current Ratio 0.91
Quick Ratio 0.84
Altman-Z -0.67
F-Score4
WACC10.91%
ROIC/WACC1.72
Cap/Depr(3y)65.89%
Cap/Depr(5y)60.54%
Cap/Sales(3y)3.86%
Cap/Sales(5y)3.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-153.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%966.67%
EPS Next Y516.5%
EPS Next 2Y256.51%
EPS Next 3Y192.01%
EPS Next 5YN/A
Revenue 1Y (TTM)-2.84%
Revenue growth 3Y27.35%
Revenue growth 5Y19.93%
Sales Q2Q%-0.4%
Revenue Next Year-3.78%
Revenue Next 2Y-0.52%
Revenue Next 3Y4.23%
Revenue Next 5YN/A
EBIT growth 1Y14.58%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year470.54%
EBIT Next 3Y101.95%
EBIT Next 5YN/A
FCF growth 1Y-77.08%
FCF growth 3Y-17.41%
FCF growth 5YN/A
OCF growth 1Y-74.45%
OCF growth 3Y-6.86%
OCF growth 5Y49.76%